Clinical Trials Logo

Clinical Trial Summary

The provision of medical services in an inner city Emergency Department (ED) provides a critical opportunity to identify and characterize future timing and pattern of service use among youth with drug use, who may be missed in school-based samples, and who may not yet be in the criminal justice system. Currently, there is a paucity of data on the timing, pattern, barriers, and trajectory of youth with multiple risks (illicit drug use and ED visit for acute violence related injury) in terms of their intersection with health services (substance use treatment, mental health, medical) and criminal justice system, which limits the development of optimal timing and setting for interventions. Youth treated in the ED may have exacerbated rates of illicit drug use, and other risk behaviors (i.e. delinquency, HIV risk behaviors, weapon carriage) and different trajectories of outcomes and interactions with service use sectors based on presentation for intentional injury as compared to other complaints (medical, unintentional injuries). Understanding the outcomes and service utilization among inner-city youth with drug use with and without acute violent injury is critically important in developing prevention and treatment services to address these multiple risk factors. The investigators propose a prospective observational study over a two-year period to identify a high risk group of youth with past year illicit drug use (N=650) seeking care in an inner city ED. The specific aims of the study, chosen to obtain data necessary to determine the location and content of subsequent interventions, are: (1) To describe characteristics of youth (ages 14-24; n=650) who report illicit drug use presenting to an urban ED for an acute violent injury (n=350), compared to youth with drug use who seek non-violence related ED care (n=300), including demographic characteristics, problem severity (e.g., substance use, violence, HIV risk behaviors, etc.), enabling factors, and service utilization (i.e., substance use treatment, mental health, and medical); (2) To identify the trajectories of participants' interactions with health services during the two years following their ED visit and the key characteristics (i.e., predisposing, enabling, and need factors) associated with types of service use (substance abuse treatment, mental health, and medical/ ED) and barriers to these services; and, (3) To measure two-year outcomes for this cohort and to identify key demographic and clinical characteristics of youth with drug use, who have poor outcomes in the two years after ED visit for intentional injury and other medical care.


Clinical Trial Description

n/a


Study Design

Observational Model: Case Control, Time Perspective: Prospective


Related Conditions & MeSH terms


NCT number NCT01152970
Study type Observational
Source University of Michigan
Contact
Status Completed
Phase N/A
Start date November 2009
Completion date December 2013

See also
  Status Clinical Trial Phase
Recruiting NCT06020391 - Cooperation for Better Treatment of Polypharmacy in the Community N/A
Completed NCT02490345 - Gabapentin as Adjunctive Treatment for Postoperative Pain Control Phase 1
Completed NCT01931683 - Dosing Study of Remifentanil for Smooth Removal of the Laryngeal Mask Airway (LMA) Phase 4
Withdrawn NCT03938077 - A Community-University Approach to Preventing HIV N/A
Completed NCT02973724 - EC95 of Remifentanil for Preventing Cough N/A
Completed NCT03330782 - Remifentanil for Preventing Propofol Injection Pain in Elderly Patients Phase 4
Completed NCT01489683 - Intubating Conditions During Propofol-remifentanil Anesthesia With Topical Lidocaine N/A
Completed NCT03368456 - Preventing HIV/STI in Urban Adolescents Via an mHealth Primary Care Intervention N/A
Completed NCT02379455 - Cooperation for Improved Pharmacotherapy in Home-dwelling Elderly People Receiving Polypharmacy - The COOP Study N/A
Completed NCT01852539 - Dexmedetomidine for Laryngeal Mask Airway Insertion Phase 4
Completed NCT01963130 - Does Vildagliptin Affect Portal Vein Pressure In Patients With Type 2 Diabetes Mellitus? A Cross Sectional Study N/A
Recruiting NCT01496105 - Efficacy Study of Topical Application of Lidacaine Spray Prior to IUD Insertion Phase 4
Completed NCT02334046 - Remifentanil for Smooth Emergence in Elderly Patients Phase 4
Completed NCT00876941 - Assessing Screening Plus Brief Intervention's Resulting Efficacy (ASPIRE) to Stop Drug Use Phase 3